Philadelphia Trust CO Neurocrine Biosciences Inc Transaction History
Philadelphia Trust CO
- $1.36 Billion
- Q4 2024
A detailed history of Philadelphia Trust CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Philadelphia Trust CO holds 36,410 shares of NBIX stock, worth $4.39 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
36,410
Previous 6,725
441.41%
Holding current value
$4.39 Million
Previous $775,000
541.29%
% of portfolio
0.36%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.22 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$590 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$364 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$306 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...